Medtronic's Resolute Efficacy On Par With Abbott's Xience In One-Year Study

One-year efficacy results reported May 25 at the EuroPCR meeting in Paris could help Medtronic claim a bigger stake in the drug-eluting stent market, where Abbott and Boston Scientific have increasingly dominated